• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:张熠,陈银,张红雷,刘伟婷,刘用国,李孝栋.参白纳米混悬剂调节免疫低下小鼠免疫功能的作用[J].药学研究,2025,44(12):1165-1172[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2128次   下载 778次 本文二维码信息
码上扫一扫!
参白纳米混悬剂调节免疫低下小鼠免疫功能的作用
张熠1,陈银1,张红雷1,刘伟婷2,刘用国1,李孝栋2
字体:加大+|默认|缩小-
(1.福建省食品药品质量检验研究院,福建 福州 350001;2.福建中医药大学药学院,福建 福州 350122)
摘要:
目的 研究参白纳米混悬剂对环磷酰胺诱导免疫低下小鼠的免疫调节作用,揭示细胞因子和蛋白水平表达的作用机制。方法 动物SPF级BALB/c雌性小鼠随机分为对照组、模型组、参白纳米混悬剂组(高、中、低)和西药对照组(盐酸左旋咪唑,30 mg·kg-1),除对照组外,其他各组小鼠腹腔注射环磷酰胺制备免疫低下小鼠模型。造模成功后,参白纳米混悬剂组和西药对照组分别给予灌胃干预30 d。观察各组小鼠的一般状态和体质量变化,检测免疫器官指数;苏木素-伊红染色法观察脾脏病理变化;酶联免疫吸附法测定细胞因子白细胞介素-2(IL-2)、干扰素-γ(IFN-γ)、小鼠肿瘤坏死因子α(TNF-α);实时荧光定量聚合酶链反应法与蛋白免疫印迹法检测脾脏组织中NF-κB p65和IκBα mRNA与TLR-4、IKKα、NF-κB p50、NF-κB p65、IκBα蛋白的表达水平。结果 与模型组比较,样品各剂量组对ConA诱导的小鼠脾淋巴细胞转化差异有统计学意义(P<0.05);样品中、高剂量组对血清溶血素、NK细胞活性检测差异有统计学意义(P<0.05);样品中剂量组对小鼠迟发型变态反应(DTH)差异有统计学意义(P<0.05);对小鼠碳廓清能力、抗体生成细胞、血清溶血素、小鼠巨噬细胞吞噬鸡红细胞差异虽无统计学意义,但各剂量组检测结果均高于模型组。与模型组相比,样品各剂量组白细胞、淋巴细胞、IL-2与IFN-γ水平增加(P<0.05);中高剂量组与模型组比较,TNF-α水平升高(P<0.05),且低剂量组计数值高于模型组。脾组织中NF-κB p65 mRNA与TLR-4、IKKα、NF-κB p50、NF-κB p65蛋白的表达水平升高(P<0.05),IκBα mRNA和蛋白表达水平下降(P<0.05)。结论 参白纳米混悬剂通过调控细胞因子IL-2、IFN-γ、TNF-α和蛋白NF-κB信号通路改善机体免疫功能,达到增强免疫低下小鼠免疫功能的作用,为其提高免疫功能的保健食品研发奠定坚实基础。
关键词:  参白纳米混悬剂  免疫低下小鼠  免疫功能  细胞因子  蛋白表达
DOI:10.13506/j.cnki.jpr.2025.12.004
基金项目:福建省高校产学合作项目(No.2021Y4016);福建省教育厅和工业信息化厅技术创新重点攻关及产业化项目(No.2023XQ014)
出版日期:2025-12-25
Research on the immunomodulatory effects of Shenbai Nanosuspension in immunocompromised mice
ZHANG Yi1,CHEN Yin1,ZHANG Honglei1,LIU Weiting2,LIU Yongguo1,LI Xiaodong2
(1.Fujian Institute For Food And Drug Quality Control,Fuzhou 350001,China;2.Pharmacy of College, Fujian University of Traditional Chinese Medicine,Fuzhou 350122,China)
Abstract:
Objective To investigate the immunomodulatory effect of Shenbai Nanosuspension on cyclophosphamide-induced immunosuppressed mice, reveal the mechanism of action based on cytokines and protein levels. Methods SPF-grade female BALB/c mice were randomly divided into six groups, including normal group, model group, low, medium, and high dose groups of Shenbai Nanosuspension and positive control group (levamisole hydrochloride, 30 mg·kg-1) . In addition to the control group, other groups of mice were injected with cyclophosphamide to prepare an immunocompromised model. Except for the control group, the other groups were intervened by for 30 days. Body weight and the general state of mice were measured; The immune organ index was examined. Cytokines of tumor necrosis factor-α(TNF-α), interleukin-2(IL-2), and interferon-γ(IFN-γ) were determined by enzyme-linked immunosorbent assay(ELISA); Hematoxylin-eosin(HE) staining was used to observe the histopathologic changes in a spleen; qRT-PCR was used to detect expression levels of NF-κB p65 and IκBα mRNA in spleen. The expression levels of NF-κB p65 and IκBα protein in spleen were detected by western blotting. Results Compared with the model group, there were significant differences among the dose groups in the ConA induced splenic lymphocyte transformation test(P<0.05). There was a significant difference in the high and medium dose group of the serum hemolysin level and natural killer cell (NK) activity (P<0.05). There was a significant difference in the medium dose group of the delayed type hypersensitivity (DTH) (P<0.05). There was no significant difference in carbon clearance, antibodies-generated cells assay and phagocytosis of chicken red blood cells (P>0.05).but the detection results of each dose group higher than those of the model group. Compared with the model group, the levels of white blood cells, lymphocytes, and cytokines (IL-2 and IFN-γ) were significantly increased in each dose group of the sample (P<0.05); The cytokines (TNF-α) were significantly higher in the middle and high dose groups(P<0.05).Meanwhile the low dose group had a higher count than the model group. Expression levels of NF-κB p65 mRNA and proteins(TLR-4,IKKα,NF-κB p50,NF-κB p65) were significantly increased(P<0.05);The expression levels of IκBα mRNA and protein were reduced (P<0.05).Conclusion Shenbai Nanosuspension regulates the immune function by modulating key signaling factors of the cytokines IL-2,IFN-γ,TNF-α and the protein NF-κB signaling pathway. It can improve the immune function of immunocompromised mice.Those lay a solid foundation for the research and development of health food to improve immune function.
Key words:  Shenbai Nanosuspension  Immunocompromised mice  Immunological function  Cytokines  Protein expression
今日访问量:2469    总访问量:55338898
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司